Healthcare Utilization and Cost Effects of Prior Authorization for Pregabalin in Commercial Health Plans
Prior authorization for pregabalin in commercial insurance plans accomplished the objective of lower pregabalin utilization; however, there was no significant decrease in disease-related healthcare costs.
Financial and Clinical Characteristics of Fibromyalgia: A Case-Control Comparison
Effects of a Medicaid Prior Authorization Policy for Pregabalin
State Medicaid programs’ pregabalin prior authorization accomplished the objective of lower pregabalin utilization; the unintended effects were increased opioid use and increased disease-related healthcare costs.
